Equity ratings for Opko Health are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 22, 2019 and ending today October 20, 2019. Click here to learn more.
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida. Opko Health operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 5690 people. more
Opko Health (OPK) is traded on BATS Exchange in USA. It is located in 4400 Biscayne Boulevard and employs 5,690 people. Opko Health is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 1.26 B. Opko Health runs under Healthcare sector within Drug Manufacturers - Specialty & Generic industry. The entity has 615.6 M outstanding shares of which 85.98 M shares are now shorted by investors with about 26.01 days to cover shorted positions.
OPKO HEALTH INC. has about 111.11 M in cash with (59.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18.
Check Opko Health Probability Of Bankruptcy
Based on normal probability distribution, the odds of Opko Health to move above current price in 30 days from now is about 9.74 (This Opko Health probability density function shows the probability of Opko Health Stock to fall within a particular range of prices over 30 days) .